1. Phase 2 study of pembrolizumab in patients with advanced rare cancers. Issue 1 (17th March 2020) Authors: Naing, Aung; Meric-Bernstam, Funda; Stephen, Bettzy; Karp, Daniel D; Hajjar, Joud; Rodon Ahnert, Jordi; Piha-Paul, Sarina A; Colen, Rivka R; Jimenez, Camilo; Raghav, Kanwal P; Ferrarotto, Renata; Tu, Shi-Ming; Campbell, Matthew; Wang, Linghua; Sabir, Sarjeel H; Tapia, Coya; Bernatchez, Chantale; ... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗